BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11060035)

  • 1. The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3.
    Rödel B; Tavassoli K; Karsunky H; Schmidt T; Bachmann M; Schaper F; Heinrich P; Shuai K; Elsässer HP; Möröy T
    EMBO J; 2000 Nov; 19(21):5845-55. PubMed ID: 11060035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells.
    Junicho A; Matsuda T; Yamamoto T; Kishi H; Korkmaz K; Saatcioglu F; Fuse H; Muraguchi A
    Biochem Biophys Res Commun; 2000 Nov; 278(1):9-13. PubMed ID: 11071847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
    Nishimoto A; Yu Y; Lu Z; Mao X; Ren Z; Watowich SS; Mills GB; Liao WS; Chen X; Bast RC; Luo RZ
    Cancer Res; 2005 Aug; 65(15):6701-10. PubMed ID: 16061651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM8 modulates STAT3 activity through negative regulation of PIAS3.
    Okumura F; Matsunaga Y; Katayama Y; Nakayama KI; Hatakeyama S
    J Cell Sci; 2010 Jul; 123(Pt 13):2238-45. PubMed ID: 20516148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
    Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
    Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cells.
    Yu CY; Wang L; Khaletskiy A; Farrar WL; Larner A; Colburn NH; Li JJ
    Oncogene; 2002 Jun; 21(25):3949-60. PubMed ID: 12037677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T; Ma J; Cao X
    Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of tyrosine phosphatase PTP1D in the inhibition of interleukin-6-induced Stat3 signaling by alpha-thrombin.
    Gunaje JJ; Bhat GJ
    Biochem Biophys Res Commun; 2001 Oct; 288(1):252-7. PubMed ID: 11594781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STRA13 interacts with STAT3 and modulates transcription of STAT3-dependent targets.
    Ivanova AV; Ivanov SV; Zhang X; Ivanov VN; Timofeeva OA; Lerman MI
    J Mol Biol; 2004 Jul; 340(4):641-53. PubMed ID: 15223310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibition of Stat3 signal transduction by PIAS3.
    Chung CD; Liao J; Liu B; Rao X; Jay P; Berta P; Shuai K
    Science; 1997 Dec; 278(5344):1803-5. PubMed ID: 9388184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
    Mora LB; Buettner R; Seigne J; Diaz J; Ahmad N; Garcia R; Bowman T; Falcone R; Fairclough R; Cantor A; Muro-Cacho C; Livingston S; Karras J; Pow-Sang J; Jove R
    Cancer Res; 2002 Nov; 62(22):6659-66. PubMed ID: 12438264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
    Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
    J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and chromosomal assignment of a human gene encoding protein inhibitor of activated STAT3 (PIAS3).
    Ueki N; Seki N; Yano K; Saito T; Masuho Y; Muramatsu M
    J Hum Genet; 1999; 44(3):193-6. PubMed ID: 10319586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of STAT3 activity by Duplin, which is a negative regulator of the Wnt signal.
    Yamashina K; Yamamoto H; Chayama K; Nakajima K; Kikuchi A
    J Biochem; 2006 Feb; 139(2):305-14. PubMed ID: 16452319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2.
    Rahaman SO; Vogelbaum MA; Haque SJ
    Cancer Res; 2005 Apr; 65(7):2956-63. PubMed ID: 15805299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enigma of the role of protein inhibitor of activated STAT3 (PIAS3) in the immune response.
    Yagil Z; Nechushtan H; Kay G; Yang CM; Kemeny DM; Razin E
    Trends Immunol; 2010 May; 31(5):199-204. PubMed ID: 20181527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular interactions between STAT3 and protein inhibitor of activated STAT3, and androgen receptor.
    Yamamoto T; Sato N; Sekine Y; Yumioka T; Imoto S; Junicho A; Fuse H; Matsuda T
    Biochem Biophys Res Commun; 2003 Jun; 306(2):610-5. PubMed ID: 12804609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
    Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
    Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.